See more : China Metal Products Co., Ltd. (1532.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Centro de Imagem Diagnósticos S.A. (AALR3.SA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Centro de Imagem Diagnósticos S.A., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Littelfuse, Inc. (LFUS) Income Statement Analysis – Financial Results
- Kinden Corporation (1944.T) Income Statement Analysis – Financial Results
- Giyani Metals Corp. (EMM.V) Income Statement Analysis – Financial Results
- Yourgene Health Plc (YGEN.L) Income Statement Analysis – Financial Results
- CoBank, ACB (CBKPP) Income Statement Analysis – Financial Results
Centro de Imagem Diagnósticos S.A. (AALR3.SA)
About Centro de Imagem Diagnósticos S.A.
Centro de Imagem Diagnósticos S.A. provides diagnostic medicine services in Brazil. Its diagnostic medicine services include imaging diagnosis and chart-based diagnosis; nuclear medicine and cytology; pathological anatomy; and clinical tests. The company also engages in the provision of health consulting, advisory, courses and lectures, and the services related to health; management of chronic diseases; scientific and technologic research and development related to diagnostic medicine; preparation, issue, publication, and distribution of newspapers, books, magazines, periodicals, and other media for the dissemination of scientific knowledge; and grant and management of business franchises. Centro de Imagem Diagnósticos S.A. was founded in 1992 and is headquartered in São Paulo, Brazil.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.09B | 1.14B | 928.79M | 1.07B | 1.08B | 1.08B | 951.47M | 699.66M | 393.15M | 275.90M | 184.19M |
| Cost of Revenue | 814.78M | 759.26M | 780.53M | 763.47M | 788.05M | 787.54M | 756.58M | 591.02M | 422.18M | 259.65M | 166.04M | 87.17M |
| Gross Profit | 364.80M | 325.75M | 356.04M | 165.32M | 284.82M | 289.38M | 321.30M | 360.45M | 277.48M | 133.50M | 109.86M | 97.02M |
| Gross Profit Ratio | 30.93% | 30.02% | 31.33% | 17.80% | 26.55% | 26.87% | 29.81% | 37.88% | 39.66% | 33.96% | 39.82% | 52.68% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 325.08M | 338.41M | 261.93M | 172.16M | 159.02M | 175.72M | 216.14M | 257.28M | 183.15M | 101.31M | 79.51M | 50.45M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 325.08M | 338.41M | 261.93M | 172.16M | 159.02M | 175.72M | 216.14M | 257.28M | 183.15M | 101.31M | 79.51M | 50.45M |
| Other Expenses | 824.00K | 30.45M | 11.89M | 14.55M | 399.00K | -8.73M | 48.67M | 12.70M | 0.00 | 2.40M | 0.00 | 0.00 |
| Operating Expenses | 325.90M | 368.86M | 273.82M | 186.71M | 159.42M | 166.99M | 264.81M | 269.98M | 168.75M | 103.71M | 76.72M | 65.84M |
| Cost & Expenses | 1.14B | 1.13B | 1.05B | 950.17M | 947.47M | 954.53M | 1.02B | 861.00M | 590.93M | 363.36M | 242.76M | 153.01M |
| Interest Income | 1.28M | 1.17M | 1.60M | 2.50M | 2.69M | 4.43M | 8.50M | 5.83M | 1.44M | 0.00 | 7.22M | 4.41M |
| Interest Expense | 247.00M | 151.48M | 84.32M | 55.56M | 61.54M | 51.31M | 65.98M | 67.36M | 58.18M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 113.36M | 117.74M | 119.60M | 119.18M | 117.87M | 82.62M | 79.02M | 54.37M | 35.70M | 36.58M | 26.14M | 13.25M |
| EBITDA | 154.73M | 49.76M | 206.49M | 98.33M | 237.98M | 204.34M | 134.64M | 146.21M | 89.96M | 66.37M | 56.27M | 45.51M |
| EBITDA Ratio | 13.12% | 5.06% | 17.66% | 1.66% | 22.05% | 18.64% | 13.82% | 24.25% | 10.02% | 16.88% | 20.39% | 24.71% |
| Operating Income | 38.90M | -62.86M | 81.06M | -103.77M | 118.65M | 137.29M | 70.34M | 100.61M | 108.74M | 29.79M | 30.13M | 32.26M |
| Operating Income Ratio | 3.30% | -5.79% | 7.13% | -11.17% | 11.06% | 12.75% | 6.53% | 10.57% | 15.54% | 7.58% | 10.92% | 17.52% |
| Total Other Income/Expenses | -238.37M | -170.38M | -79.77M | -51.68M | -59.69M | -52.35M | -64.41M | -55.85M | -101.77M | -35.40M | -4.21M | 3.33M |
| Income Before Tax | -199.47M | -233.23M | 2.46M | -73.07M | 65.71M | 70.05M | -7.92M | 34.62M | 6.97M | -5.61M | 25.92M | 35.59M |
| Income Before Tax Ratio | -16.91% | -21.50% | 0.22% | -7.87% | 6.12% | 6.50% | -0.74% | 3.64% | 1.00% | -1.43% | 9.39% | 19.32% |
| Income Tax Expense | 19.09M | -13.99M | 468.00K | 19.36M | 15.64M | 18.48M | -22.56M | 5.85M | 18.40M | -1.27M | 884.00K | 6.85M |
| Net Income | -227.88M | -219.24M | 1.99M | -92.43M | 41.30M | 40.09M | 6.65M | 14.79M | -12.77M | -4.17M | 27.68M | 28.51M |
| Net Income Ratio | -19.32% | -20.21% | 0.17% | -9.95% | 3.85% | 3.72% | 0.62% | 1.55% | -1.82% | -1.06% | 10.03% | 15.48% |
| EPS | -1.93 | -1.86 | 0.02 | -0.78 | 0.35 | 0.34 | 0.06 | 0.15 | -0.14 | -0.07 | 0.55 | 0.59 |
| EPS Diluted | -1.93 | -1.86 | 0.02 | -0.78 | 0.35 | 0.34 | 0.06 | 0.15 | -0.14 | -0.07 | 0.55 | 0.59 |
| Weighted Avg Shares Out | 118.29M | 117.82M | 117.55M | 118.04M | 118.04M | 118.20M | 116.80M | 101.15M | 91.85M | 56.51M | 50.20M | 48.59M |
| Weighted Avg Shares Out (Dil) | 118.29M | 117.82M | 117.55M | 118.04M | 118.04M | 118.54M | 117.14M | 101.15M | 92.20M | 56.51M | 50.20M | 48.59M |
Source: https://incomestatements.info
Category: Stock Reports